Semcon

Activities: Digital

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  3. Naobios and Sumagen sign exclusive partnership to develop HIV vaccine Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials
  4. Rapid increase in purchasing teams expected at CPHI North America Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
  5. Bio-Rad and Oncocyte partner to commercialise transplant monitoring with Droplet Digital PCR The collaboration aims to provide researchers with tools to enable transformational monitoring of key biomarkers in solid tissue transplants

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Media

New framework agreement concluded with AstraZeneca

International technology company Semcon, developer of products based on human needs and behaviours has signed the agreement with the multinational pharmaceutical company
Subscribe now